|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Bristol-Myers Squibb Company |
BMY |
110122108 |
Pharmaceuticals |
18,970 |
$1,138,579.40 |
7.58% |
| Johnson & Johnson |
JNJ |
478160104 |
Pharmaceuticals |
6,854 |
$1,122,068.34 |
7.47% |
| AbbVie Inc. |
ABBV |
00287Y109 |
Pharmaceuticals |
5,411 |
$1,110,824.19 |
7.39% |
| Merck & Co., Inc. |
MRK |
58933Y105 |
Pharmaceuticals |
12,260 |
$1,093,959.80 |
7.28% |
| Pfizer Inc. |
PFE |
717081103 |
Pharmaceuticals |
42,793 |
$1,078,811.53 |
7.18% |
| Amgen Inc. |
AMGN |
031162100 |
Pharmaceuticals |
1,836 |
$563,560.20 |
3.75% |
| Biogen Inc. |
BIIB |
09062X103 |
Biotechnology |
4,025 |
$556,939.25 |
3.71% |
| Gilead Sciences, Inc. |
GILD |
375558103 |
Pharmaceuticals |
4,947 |
$553,025.13 |
3.68% |
| Zoetis Inc. |
ZTS |
98978V103 |
Pharmaceuticals |
3,381 |
$551,474.91 |
3.67% |
| United Therapeutics Corporation |
UTHR |
91307C102 |
Pharmaceuticals |
1,767 |
$542,415.99 |
3.61% |
| Viatris Inc. |
VTRS |
92556V106 |
Pharmaceuticals |
61,269 |
$531,814.92 |
3.54% |
| Regeneron Pharmaceuticals, Inc. |
REGN |
75886F107 |
Biotechnology |
809 |
$515,624.24 |
3.43% |
| Eli Lilly and Company |
LLY |
532457108 |
Pharmaceuticals |
614 |
$505,021.14 |
3.36% |
| Jazz Pharmaceuticals Plc |
JAZZ |
G50871105 |
Pharmaceuticals |
3,940 |
$484,304.80 |
3.22% |
| Organon & Co. |
OGN |
68622V106 |
Pharmaceuticals |
27,431 |
$398,023.81 |
2.65% |
| Charles River Laboratories International, Inc. |
CRL |
159864107 |
Biotechnology |
1,963 |
$305,344.65 |
2.03% |
| Exelixis, Inc. |
EXEL |
30161Q104 |
Biotechnology |
7,725 |
$283,507.50 |
1.89% |
| Medpace Holdings, Inc. |
MEDP |
58506Q109 |
Biotechnology |
859 |
$268,317.24 |
1.79% |
| Elanco Animal Health Incorporated |
ELAN |
28414H103 |
Pharmaceuticals |
23,129 |
$240,772.89 |
1.60% |
| Illumina, Inc. |
ILMN |
452327109 |
Biotechnology |
2,959 |
$236,720.00 |
1.57% |
| Halozyme Therapeutics, Inc. |
HALO |
40637H109 |
Biotechnology |
3,591 |
$229,249.44 |
1.53% |
| Neurocrine Biosciences, Inc. |
NBIX |
64125C109 |
Biotechnology |
1,788 |
$202,330.08 |
1.35% |
| BioMarin Pharmaceutical Inc. |
BMRN |
09061G101 |
Pharmaceuticals |
2,780 |
$198,603.20 |
1.32% |
| Alkermes Plc |
ALKS |
G01767105 |
Pharmaceuticals |
5,046 |
$167,577.66 |
1.11% |
| Perrigo Company Plc |
PRGO |
G97822103 |
Pharmaceuticals |
5,138 |
$144,172.28 |
0.96% |
| Amneal Pharmaceuticals, Inc. |
AMRX |
03168L105 |
Pharmaceuticals |
15,042 |
$124,547.76 |
0.83% |
| Prestige Consumer Healthcare Inc. |
PBH |
74112D101 |
Pharmaceuticals |
1,385 |
$117,849.65 |
0.78% |
| Catalyst Pharmaceuticals, Inc. |
CPRX |
14888U101 |
Biotechnology |
4,636 |
$114,462.84 |
0.76% |
| TG Therapeutics, Inc. |
TGTX |
88322Q108 |
Biotechnology |
2,591 |
$103,277.26 |
0.69% |
| ADMA Biologics, Inc. |
ADMA |
000899104 |
Biotechnology |
4,757 |
$96,376.82 |
0.64% |
| Alnylam Pharmaceuticals, Inc. |
ALNY |
02043Q107 |
Biotechnology |
316 |
$84,833.36 |
0.56% |
| Cardinal Health, Inc. |
CAH |
14149Y108 |
Pharmaceuticals |
602 |
$82,136.88 |
0.55% |
| Guardant Health, Inc. |
GH |
40131M109 |
Biotechnology |
1,832 |
$79,032.48 |
0.53% |
| Krystal Biotech, Inc. |
KRYS |
501147102 |
Biotechnology |
435 |
$80,005.20 |
0.53% |
| Vertex Pharmaceuticals Incorporated |
VRTX |
92532F100 |
Pharmaceuticals |
162 |
$79,815.78 |
0.53% |
| PTC Therapeutics, Inc. |
PTCT |
69366J200 |
Biotechnology |
1,411 |
$76,532.64 |
0.51% |
| Insmed Incorporated |
INSM |
457669307 |
Biotechnology |
956 |
$74,558.44 |
0.50% |
| Madrigal Pharmaceuticals, Inc. |
MDGL |
558868105 |
Biotechnology |
228 |
$74,754.36 |
0.50% |
| Axsome Therapeutics, Inc. |
AXSM |
05464T104 |
Biotechnology |
611 |
$72,421.83 |
0.48% |
| Blueprint Medicines Corporation |
BPMC |
09627Y109 |
Pharmaceuticals |
807 |
$71,597.04 |
0.48% |
| Exact Sciences Corporation |
EXAS |
30063P105 |
Biotechnology |
1,644 |
$71,777.04 |
0.48% |
| Corcept Therapeutics Inc. |
CORT |
218352102 |
Pharmaceuticals |
1,287 |
$70,308.81 |
0.47% |
| ACADIA Pharmaceuticals Inc. |
ACAD |
004225108 |
Biotechnology |
3,978 |
$67,904.46 |
0.45% |
| Akero Therapeutics, Inc. |
AKRO |
00973Y108 |
Biotechnology |
1,587 |
$67,796.64 |
0.45% |
| Veracyte, Inc. |
VCYT |
92337F107 |
Biotechnology |
2,243 |
$67,559.16 |
0.45% |
| Vericel Corporation |
VCEL |
92346J108 |
Biotechnology |
1,520 |
$67,640.00 |
0.45% |
| Scholar Rock Holding Corporation |
SRRK |
80706P103 |
Biotechnology |
2,008 |
$65,942.72 |
0.44% |
| Incyte Corporation |
INCY |
45337C102 |
Biotechnology |
1,061 |
$64,296.60 |
0.43% |
| SpringWorks Therapeutics, Inc. |
SWTX |
85205L107 |
Biotechnology |
1,350 |
$64,003.50 |
0.43% |
| Sarepta Therapeutics, Inc. |
SRPT |
803607100 |
Biotechnology |
730 |
$51,399.30 |
0.34% |
| US Dollar |
$USD |
|
Other |
16,420 |
$16,420.04 |
0.11% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|